WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, July 20, 2005, 25(29):6765-6774; doi:10.1523/JNEUROSCI.1700-05.2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beier, C. P.
Right arrow Articles by Schulz, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beier, C. P.
Right arrow Articles by Schulz, J. B.

 Previous Article  |  Next Article 

Neurobiology of Disease
FasL (CD95L/APO-1L) Resistance of Neurons Mediated by Phosphatidylinositol 3-Kinase-Akt/Protein Kinase B-Dependent Expression of Lifeguard/Neuronal Membrane Protein 35

Christoph P. Beier,1 Jörg Wischhusen,2 Marc Gleichmann,1 Ellen Gerhardt,1,3 Ana Pekanovic,1,3 Andreas Krueger,4 Verdon Taylor,5 Ueli Suter,5 Peter H. Krammer,4 Matthias Endres,6 Michael Weller,2 and Jörg B. Schulz1,3

Laboratories of 1Neurodegeneration and 2Molecular Neurooncology, Department of Neurology, Medical School, University of Tübingen, 72076 Tübingen, Germany, 3Department of Neurodegeneration and Restorative Research, Center of Molecular Physiology of the Brain and Center of Neurological Medicine, University of Göttingen, 37073 Göttingen, Germany, 4Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, 69120 Heidelberg, Germany, 5Institute of Cell Biology, Department of Biology, Eidgenössische Technische Hochschule, 8093 Zürich, Switzerland, and 6Department of Neurology, Charité, Humboldt University, 10117 Berlin, Germany

The contribution of Fas (CD95/APO-1) to cell death mechanisms of differentiated neurons is controversially discussed. Rat cerebellar granule neurons (CGNs) express high levels of Fas in vitro but are resistant to FasL (CD95L/APO-1L/CD178)-induced apoptosis. We here show that this resistance was mediated by a phosphatidylinositol 3-kinase (PI 3-kinase)-Akt/protein kinase B (PKB)-dependent expression of lifeguard (LFG)/neuronal membrane protein 35. Reduction of endogenous LFG expression by antisense oligonucleotides or small interfering RNA lead to increased sensitivity of CGNs to FasL-induced cell death and caspase-8 cleavage. The inhibition of PI 3-kinase activity sensitized CGNs to FasL-induced caspase-8 and caspase-3 processing and caspase-dependent fodrin cleavage. Pharmacological inhibition of PI 3-kinase, overexpression of the inhibitory protein I{kappa}B, or cotransfection of an LFG reporter plasmid with dominant-negative Akt/PKB inhibited LFG reporter activity, whereas overexpression of constitutively active Akt/PKB increased LFG reporter activity. Overexpression of LFG in CGNs interfered with the sensitization to FasL by PI 3-kinase inhibitors. In contrast to CGNs, 12 glioma cell lines, which are sensitive to FasL, did not express LFG. Gene transfer of LFG into these FasL-susceptible glioma cells protected against FasL-induced apoptosis. These results demonstrate that LFG mediated the FasL resistance of CGNs and that, under certain circumstances, e.g., inhibition of the PI 3-kinase-Akt/PKB pathway, CGNs were sensitized to FasL.

Key words: apoptosis; Fas/CD95; lifeguard; cerebellar granule neurons; PI 3-kinase/Akt; caspase


Received Dec 30, 2004; revised June 1, 2005; accepted June 1, 2005.




This article has been cited by other articles:


Home page
Cancer Res.Home page
D. Beier, S. Rohrl, D. R. Pillai, S. Schwarz, L. A. Kunz-Schughart, P. Leukel, M. Proescholdt, A. Brawanski, U. Bogdahn, A. Trampe-Kieslich, et al.
Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma
Cancer Res., July 15, 2008; 68(14): 5706 - 5715.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. F. Segura, C. Sole, M. Pascual, R. S. Moubarak, M. Jose Perez-Garcia, R. Gozzelino, V. Iglesias, N. Badiola, J. R. Bayascas, N. Llecha, et al.
The Long Form of Fas Apoptotic Inhibitory Molecule Is Expressed Specifically in Neurons and Protects Them against Death Receptor-Triggered Apoptosis
J. Neurosci., October 17, 2007; 27(42): 11228 - 11241.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-